Salivary transcriptome of the North American medicinal leech, Macrobdella decora
Min GS, Sarkar IN, Siddall ME (2010) · Journal of Parasitology · n=0
Study Profile
- Design
- expressed sequence tag (EST) library-based analysis of the salivary transcriptome of the North American medicinal leech Macrobdella decora (Department of Biological Sciences, Inha University, Korea; with US co-authors)
- Sample size (n)
- 0
- Intervention
- EST library construction and sequence-homology-based identification of bioactive salivary transcripts in M. decora; phylogenetic comparison with European/Asian Hirudo species and other sanguivorous annelids
- Comparator
- Cross-species transcriptome comparison with H. medicinalis and related leech salivary literature
- Primary endpoint
- Identification of bioactive transcript classes in the North American medicinal leech; comparison with previously characterized leech salivary components
- Primary result
- M. decora salivary transcriptome contains transcripts corresponding to saratin, bdellin, destabilase, hirudin, decorsin, endoglucoronidase, antistatin, eglin, as well as previously uncharacterized serine protease inhibitors, lectoxin-like c-type lectins, ficolin, disintegrins, and histidine-rich proteins; the comprehensive richness of bioactive polypeptides supports the long-recognized clinical analgesic and anticoagulant effects of sanguivorous leeches; molecular phylogeny provides preliminary evaluation of evolutionary origins and historical conservation of leech salivary components
- Follow-up duration
- not applicable (transcriptome and phylogeny analysis)
- PMID
- 21158638
Key Findings
- First comprehensive salivary transcriptome of the North American medicinal leech, Macrobdella decora
- Confirms presence of canonical leech salivary bioactive families (hirudin, decorsin, antistatin, eglin, bdellin, destabilase) in a North American species
- Identifies novel transcript classes including lectoxin-like c-type lectins, ficolin, disintegrins, and histidine-rich proteins
- Supports the case that leech-salivary bioactive diversity is conserved across geographically distant sanguivorous leech species
- Provides phylogenetic framework for understanding evolutionary origins of leech salivary pharmacology
Limitations
- EST library-based approach has lower sensitivity and depth than modern RNA-Seq
- Sequence-homology-based annotation rather than direct functional characterization
- No in vivo or in vitro pharmacology data on M. decora salivary components
- Single-species transcriptome - cross-species comparison limited to homology-based inference
- North American medicinal leech (M. decora) not currently used commercially in the US under K040187
Clinical Implications
Min 2010 documents that the North American medicinal leech (Macrobdella decora) contains the same canonical bioactive families found in European/Asian medicinal leeches, providing evolutionary support for the broad applicability of leech salivary pharmacology. For ASH editorial purposes, the trial is essential context for understanding the cross-species conservation of leech-derived therapeutic molecules. For US clinicians and research-focused readers, the trial provides important geographic context: the M. decora species native to North America has not been developed for commercial therapy (which uses imported H. verbana) but represents a potential indigenous resource for future leech-derived pharmaceutical development.
Related Trials
Medicinal leech therapy in venous congestion of microsurgical flaps: a randomized comparison with heparin pinprick scarification
Merlino G, Carbone S, Servillo G, Marletta DA (2020)
Adjunctive medicinal leech therapy for venous congestion in free flaps: a German multicenter randomized trial
Lehnhardt M, Daigeler A, Behr B, Schmidt SV, Wallner C (2021)
Medicinal leeches and the microsurgeon: a four-year study, clinical series and risk benefit review
Whitaker IS, Josty IC, Hawkins S, Azzopardi E, Naderi N, Graf J, Damaris L, Lineaweaver WC, Kon M (2011)
Medicinal leeches for surgically uncorrectable venous congestion after free flap breast reconstruction
Pannucci CJ, Nelson JA, Chung CU, Fischer JP, Kanchwala SK, Kovach SJ, Serletti JM, Wu LC (2014)